The airway microbiome in COPD, bronchiectasis and bronchiectasis ‐COPD overlap

ConclusionUse of next ‐generation sequencing has revolutionised our detection and understanding of the airway microbiome in chronic respiratory diseases such as COPD and bronchiectasis. Targeted amplicon sequencing reveals important associations between the respiratory microbiome and disease outcome while metagenomics may elucidate functional pathways. How best to apply this information into patient care, monitoring and treatment, however, remains challenging and necessitates further study.

Source: The Clinical Respiratory Journal - February 20, 2021 Category: Respiratory Medicine Authors: Pei Yee Tiew, Tavleen K. Jaggi, Louisa L. Y. Chan, Sanjay H. Chotirmall Tags: REVIEW ARTICLE Source Type: research